EverGlade Consulting Plays Key Role on Industrial Base Expansion (IBx) Project with $39 Million in Federal Funding Secured

Industrail Base Expansion (IBx) mRNA vaccine programs

CHARLESTON, S.C., Aug. 24, 2022 /PRNewswire/ — EverGlade Consulting (“EverGlade”), a national consulting firm, has successfully partnered with a global leader in mRNA materials used for research, diagnostics, and therapeutics, to successfully manage $39 million in federal funding.

Scroll to Top